Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
Variation in how health services are delivered and funded, how screening is described and how screening policy is made help explain differences between countries and regions in what conditions they screen for.
The UK National Screening Committee is recommending the introduction of screening for tyrosinaemia as part of the newborn blood spot screening programme.
The UK National Screening Committee (UK NSC) received a record number of 29 proposals during its 2022 annual call for topics. This is by far the most submissions it has received in a single year since the annual call process started in 2016.
A public dialogue on the implications of whole genome sequencing (WGS) for newborn screening, commissioned by the UK NSC, has won the 2022 Market Research Society (MRS) award for public policy/social research.
Researchers start work on new project to review evidence for newborn screening for spinal muscular atrophy.
Find out more about the role of the UK NSC's patient and public voice members (PPVs) and the essential contribution they make to the work of the committee.
Using evidence maps as the first stage in its evidence review process helps the UK NSC focus its more detailed work on topics where there is the most significant new evidence.
The UK NSC has published a new collection of documents on GOV.UK that describe its processes and principles for implementing the chief medical officers’ recommendations for the committee’s expanded remit.
The UK NSC has recommended that the 4 UK nations should move towards implementing a targeted national lung cancer screening programme, integrated with smoking cessation services.
Today, we publish a report summarising the work of the UK National Screening Committee over the past 25 years.